Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8716313

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 8716287

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 8716258

    Regulation of metabolism by miR-378

    The Board of Regents of the University of Texas System · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 8716246

    Azuvirin peptides

    The Regents of the University of California · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 8716279

    Pharmaceutical compositions of clonazepam and method of use thereof

    Jazz Pharmaceuticals, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 8716215

    Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 8716030

    Means for the inhibition of anti-β1-adrenergic receptor antibodies

    Julius-Maximillians-Universitat Wurzburg, A Germany University · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 8716017

    Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

    San Diego Regenerative Medicine Institute · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 8715968

    Methods and reagents for modulating cholesterol levels

    Xenon Pharmaceuticals Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 8715949

    Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components

    United States of America as represented by the Secretary of the Air Force · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 8715710

    Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

    Heron Therapeutics, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 8715689

    Chimeric west nile/dengue viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 8715682

    Means for the inhibition of anti-beta1-adrenergic receptor antibodies

    Julius-Maximillians-Universitat Wurzburg, A Germany University · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 8715679

    Pili from Mycobacterium tuberculosis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 8715645

    Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same

    The Regents of the University of Colorado · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 8722889

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 8722077

    Drug delivery coating for use with a stent

    ATRIUM MEDICAL CORPORATION · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 8722667

    Compositions and methods for inhibiting the proliferation of cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 8722616

    Anti-HIV peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 8722884

    Pyrimidine derivatives for the treatment of abnormal cell growth

    VERASTEM, INC. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 8722895

    Prolyl hydroxylase inhibitors and method of use

    Akebia Therapeutics, Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 8721620

    Swallowable drug delivery device and methods of drug delivery

    Rani Therapeutics, LLC · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 8722939

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 8722896

    Prokineticin receptor antagonists and uses thereof

    The Regents of the University of California · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 8722871

    VMP-like sequences of pathogenic borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 8722662

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 8725266

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 8722894

    1,3-disubstituted-4-phenyl-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 8722738

    Acetycysteine compositions and methods of use thereof

    Cumberland Pharmaceuticals Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 8722660

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 8722863

    Solid state forms of fidaxomycin and processes for preparation thereof

    Teva Pharmaceutical Works Ltd. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 8722708

    Substituted isoindolines as aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 8722732

    Oligomer-calcimimetic conjugates and related compounds

    Nektar Therapeutics · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 8722722

    Raltegravir salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 8722716

    Isoxazole treatments for diabetes

    The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 8722704

    Modulators of ATP-binding cassette-transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 8722082

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 8722653

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 8722646

    High concentration chitosan-nucleic acid polyplex compositions

    ENGENE, INC. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 8722645

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 8722628

    Autophagy-inducing peptide

    The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 8722046

    Human monoclonal antibodies protective against bubonic plague

    The United States of America as represented by the Secretary of the Army · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 8722063

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 8722132

    Application of a coating on a medical device

    ATRIUM MEDICAL CORPORATION · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 8722032

    Thiol-selective water-soluble polymer derivatives

    Nektar Therapeutics · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 8722084

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 8729026

    Method for inhibiting autophagy of motor neurons

    China Medical University · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.